You are here: Industry Insights > PrEP

News List

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention FDA
December 22, 2021
Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP)...
Black, Hispanic/Latino MSM Less Likely to Have HIV Diagnosis Drugs
December 14, 2021
Black and Hispanic/Latino men who have sex with men (MSM) are less likely than White MSM to receive an HIV diagnosis or use preexposure prophylaxis (PrEP)...
Merck Pauses Enrollment for Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis of HIV-1 infection AmericanPharmaceuticalReview
December 09, 2021
Merck announced a pause in enrollment for the IMPOWER 22 (MK-8591-022) and IMPOWER 24 (MK-8591-024) Phase 3 clinical studies evaluating investigational, once-monthly, oral islatravir (ISL), a nucleoside reverse transcriptase translocation inhibitor...
PrEP HIV Prevention Pills to Be Free for Insured Americans drugs
July 22, 2021
Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis(PrEP) drugs Truvada and Descovy, all clinic visits, and lab tests, NBC News reported.
Trial of new HIV PrEP medication stopped early due to effectiveness europeanpharmaceuticalreview
November 13, 2020
The trial was stopped because the data suggested that injections of the long-acting antiretroviral drug cabotegravir (CAB LA) are highly effective for HIV pre-exposure prophylaxis (PrEP) in women.
Long-acting injectable HIV PrEP outperforms commercially available daily pill europeanpharmaceuticalreview
July 09, 2020
Extensive analysis of interim data finds patients given cabotegravir injection had a 66 percent lower incidence of HIV acquisition than those taking Truvada pills.
PrEP to be available in England from April pharmatimes
March 18, 2020
From April, the Department of Health and Social Care will ensure that everyone at high risk of contracting HIV will receive PrEP from their local sexual health clinic.
Minor Changes in BMD Seen With Tenofovir PrEP in Short Term drugs
July 26, 2019
Tenofovir preexposure prophylaxis (PrEP) therapy does not appear to be associated with clinically significant declines in bone mineral density (BMD) in the short term...
Awareness, Use of PrEP on Rise Among Men Who Have Sex With Men drugs
July 12, 2019
Awareness, Use of PrEP on Rise Among Men Who Have Sex With Men.
Two Algorithms Can ID Patients at Risk for HIV, PrEP Candidates drugs
July 11, 2019
Two new research papers, published online in The Lancet HIV, present algorithms that can help identify patients at risk for HIV and candidates for preexposure prophylaxis (PrEP).

Previous page 1 2 Next page